Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
- PMID: 14986813
- DOI: 10.1111/j.1478-3231.2003.00869.x
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Abstract
Chronic hepatitis B virus (HBV) infection and dietary exposure to aflatoxin B1 (AFB1), two of the major risk factors in the multifactorial aetiology of hepatocellular carcinoma (HCC), co-exist in those countries with the highest incidences of and the youngest patients with this tumour, raising the possibility of a synergistic carcinogenic interaction between the two agents. Experimental studies in HBV-transgenic mice and woodchucks infected with woodchuck hepatitis virus were the first to show a synergistic hepatocarcinogenic effect between hepadnaviral infection and AFB1 exposure. With the availability of urinary and serum biomarkers that more accurately reflect dietary exposure to AFB1 than did the initially used food sampling and dietary questionnaires, cohort studies of patients with HCC in China and Taiwan have provided compelling evidence for a multiplicative or sub-multiplicative interaction between HBV and AFB1 in the genesis of human HCC. A number of possible mechanisms for the interaction have been suggested. Chronic HBV infection may induce the cytochrome P450s that metabolise inactive AFB1 to the mutagenic AFB1-8,9-epoxide. Hepatocyte necrosis and regeneration and the generation of oxygen and nitrogen reactive species resulting from chronic HBV infection increase the likelihood of the AFB1-induced p53 249ser and other mutations and the subsequent clonal expansion of cells containing these mutations. Nuclear excision repair, which is normally responsible for removing AFB1-DNA adducts, is inhibited by HBV x protein, favouring the persistence of existing mutations. This protein also increases the overall frequency of DNA mutations, including the p53 249ser mutation, and may contribute to uncontrolled cell cycling when p53 is non-functional.
Similar articles
-
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.Cancer Res. 1997 Aug 15;57(16):3471-7. Cancer Res. 1997. PMID: 9270015
-
The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.Liver Int. 2015 Mar;35(3):999-1009. doi: 10.1111/liv.12460. Epub 2014 Jan 27. Liver Int. 2015. PMID: 24461059
-
Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China.PLoS One. 2013 Dec 31;8(12):e83465. doi: 10.1371/journal.pone.0083465. eCollection 2013. PLoS One. 2013. PMID: 24391771 Free PMC article.
-
A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses.J Environ Pathol Toxicol Oncol. 2013;32(2):165-75. doi: 10.1615/jenvironpatholtoxicoloncol.2013007166. J Environ Pathol Toxicol Oncol. 2013. PMID: 24099430 Review.
-
Synergism in actions of HBV with aflatoxin in cancer development.Toxicology. 2023 Nov;499:153652. doi: 10.1016/j.tox.2023.153652. Epub 2023 Oct 18. Toxicology. 2023. PMID: 37858775 Review.
Cited by
-
Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma.Biomol Biomed. 2024 Mar 16;24(4):939-951. doi: 10.17305/bb.2024.10103. Biomol Biomed. 2024. PMID: 38498315 Free PMC article.
-
Aflatoxin exposure in a population of HIV patients at risk of hepatocellular carcinoma North-Central, Nigeria.Afr Health Sci. 2023 Jun;23(2):81-87. doi: 10.4314/ahs.v23i2.9. Afr Health Sci. 2023. PMID: 38223595 Free PMC article.
-
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.Nat Rev Clin Oncol. 2023 Dec;20(12):864-884. doi: 10.1038/s41571-023-00825-3. Epub 2023 Oct 26. Nat Rev Clin Oncol. 2023. PMID: 37884736 Review.
-
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.Gynecol Oncol. 2023 Jul;174:253-261. doi: 10.1016/j.ygyno.2023.05.011. Epub 2023 May 25. Gynecol Oncol. 2023. PMID: 37243996 Free PMC article.
-
Synthesis and Characterization of 15N5-Labeled Aflatoxin B1-Formamidopyrimidines and Aflatoxin B1-N7-Guanine from a Partial Double-Stranded Oligodeoxynucleotide as Internal Standards for Mass Spectrometric Measurements.ACS Omega. 2023 Apr 11;8(16):14841-14854. doi: 10.1021/acsomega.3c01328. eCollection 2023 Apr 25. ACS Omega. 2023. PMID: 37125130 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous